Paydirt
TRVI
Ticker

Trevi Therapeutics, Inc.

TRVI · Healthcare · Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment…

Trevi Therapeutics, Inc. (TRVI), in the Healthcare sector, has 1 disclosed filing on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 1 sale. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 15 and filed Sep 17. The most active filer was Michael Thomas Heffernan with 1 filing.

Add to watchlist
Filings, ttm
1
0 buys · 1 sell
Traders, ttm
1
1 insider
Volume, ttmiDollar value disclosed in the window
$593K
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 15
Filed Sep 17
ADViAverage daily dollar volume
$33.1M
market data
Share price · 12M
$14.95 (+74.9%)
$19.50$13.94$8.38Sep 22 2025Mar 23Sep 18

Adjusted for splits and dividends.

Volume by month
$593K$296K$0Oct 2024Apr 2025Oct 2025Apr 2026Mar 2025 · sells $518KSep 2026 · sells $593K
Buys $0 Sells $1.1M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
MH Michael Thomas Heffernan Director 1 filing FS Farrell Simon Chief Commercial Officer 1 filing
Recent filings
Michael Thomas HeffernanSALE Director $593K
39,273 sh across 2 lots
Exec Sep 15
Filed Sep 17 · 4:55 PM ET Farrell SimonSALE Chief Commercial Officer $518K
76,963 sh × $6.73
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET